Views
18
Downloands
3
Gastrointestinal semptomlar, özellikle retrosternal yanma ve regürjitasyon, son dönem böbrek hastalarında (SDBH) ve renal transplant alıcılarında sık görülen bulgulardır. Kronik böbrek hastalarında ve böbrek nakli yapılan hastalarda gastroözofageal reflü hastalığının (GÖRH) prevalansı son birkaç yıldır tartışılmaya başlamıştır. Ülkemizde renal transplant alıcılarında GÖRH prevelansı araştırılmamıştır. Bu çalışmada renal transplant alıcılarında GÖRH sıklığını ve ilişkili olduğu faktörleri araştırmayı amaçladık. Kesitsel tipteki bu çalışmaya 69 fonksiyone grefte sahip renal transplant alıcısı hasta dahil edildi. Hastaların gastrointestinal sistem şikayetleri, özgeçmiş özellikleri ve kullandıkları ilaçlar yüz yüze görüşme yöntemi ile elde edildi. Anket formu, bireylerin sosyodemografik özelliklerini, GÖRH ile ilişkili olduğu düşünülen bazı faktörler ile ilgili soruları içermekteydi. Çalışmada GÖRH’ün değerlendirilmesinde National İnstitutes of Health (NIH) PROMİS GERD Ölçeği kullanıldı. Çalışmaya dahil edilen hastaların 32’si (%46.4) erkek, 37’si (%53.6) ise kadındı. Hastaların yaşları 22-66 arasında değişmekte olup, yaş ortalamaları 44.86±11.26 yıl idi. Hastalarda GÖRH sıklığı %21.7 oranında tespit edildi. Hastaların %79.7’si gastroprotektif ajan kullanmakta idi. GÖRH olanlarla olmayanlar arasında yaş, cinsiyet, vücut kitle indeksi, glomeruler filtrasyon hızı (eGFR), sigara kullanımı, medeni durum, gastroprotektif ilaç kullanımı, nonsteroid antienflamatuar ilaç kullanımı, donor kaynağı (canlı, kadavra), nakil öncesi diyaliz süresi, eğitim durumu açısından fark bulunmadı (p>0.05). Renal transplant alıcılarında GÖRH sıklığı %21.7 bulunmuş olup, bu oranın genel Türk popülasyonu ile karşılaştırıldığında (%33.9) düşük, Türk hemodiyaliz hasta popülasyonu ile karşılaştırıldığında(%14) yüksek olduğu tesbit edilmiştir.
Gastrointestinal symptoms, especially heartburn and regurgitation, are common findings in end-stage renal disease (ESRD) and renal transplant recipients. The prevalence of gastroesophageal reflux disease (GERD) in patients with chronic kidney disease and renal transplantation has been debated over the last few years. In our country, the prevalence of GERD in renal transplant recipients has not been investigated. In this study, we aimed to investigate the frequency and associated factors of GERD in renal transplant recipients. 69 renal transplant recipients patients who have functional graft included in this cross-sectional study. Gastrointestinal complaints of the patients, resume characteristics and the medication they used were obtained by face to face interview method. The questionnaire included questions about the sociodemographic characteristics of individuals and some factors that were thought to be related to gastroesophageal reflux disease (GERD). The National Institute of Health (NIH) PROMIS GERD Scale was used to assess gastroesophageal reflux disease in the study. 32 patients (46.4%) were male and 37 (53.6%) were female in this study. The ages of the patients ranged from 22 to 66 years and the average age was 44.86 ± 11.26 years. The incidence of GERD was 21.7% in patients. 79.7% of the patients were using gastroprotective agents. There was no difference among those who have GERD and not in terms of age, sex, body mass index, glomerular filtration rate (eGFR), smoking status, marital status, gastroprotective drug use, nonsteroidal anti-inflammatory drug use, donor source (live, cadaver) ), duration of dialysis before transplantation, education status (p>0.05). GERD frequency in renal transplant recipients was found to be 21.7% and when compared with the general Turkish population (33.9%) it is low, when compared with the Turkish hemodialysis patient population (14%) it is high.
Gastrointestinal symptoms, especially heartburn and regurgitation, are common findings in end-stage renal disease (ESRD) and renal transplant recipients. The prevalence of gastroesophageal reflux disease (GERD) in patients with chronic kidney disease and renal transplantation has been debated over the last few years. In our country, the prevalence of GERD in renal transplant recipients has not been investigated. In this study, we aimed to investigate the frequency and associated factors of GERD in renal transplant recipients. 69 renal transplant recipients patients who have funtional graft included in this cross-sectional study. Gastrointestinal complaints of the patients, resume characteristics and the medication they used were obtained by face to face interview method. The questionnaire included questions about the sociodemographic characteristics of individuals and some factors that were thought to be related to gastroesophageal reflux disease (GERD). The National Institute of Health (NIH) PROMIS GERD Scale was used to assess gastroesophageal reflux disease in the study. 32 patients (46.4%) were male and 37 (53.6%) were female in this study. The ages of the patients ranged from 22 to 66 years and the mean age was 44.86 ± 11.26 years. The incidence of GERD was 21.7% in patients. 79.7% of the patients were using gastroprotective agent. There was no difference among those who have GERD and not in terms of age, sex, body mass index, glomerular filtration rate (eGFR), smoking status, marital status, gastroprotective drug use, nonsteroidal antiinflammatory drug use, donor source (live, cadaver) ), duration of dialysis before transplantation, education status (p>0.05). GERD frequency in renal transplant recipients was found to be 21.7% and when compared with the general Turkish population (33.9%) it is low, when compared with the Turkish hemodialysis patient population (14%) it is high.
Field : Sağlık Bilimleri
Journal Type : Uluslararası
Article Detail 
Similar Articles
Download PDF
Journal Information
Listen Paper
Cite
Print This Page
Share
Mendeley
